IL6 and cholangiocarcinoma: This finding is in agreement with the observation that low expression of IL-6 (indicative of stromal inflammation) along with high expression of LC3 (indicative of active autophagy) in cholangiocarcinomas associates with sensitivity to chemotherapy and better overall patient survival [59].